SAN DIEGO--(BUSINESS WIRE)--Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH), the world leader in the development of a new class of small molecule compounds based on endogenous adrenal steroid hormones, today announced that it will present at the 2008 BIO CEO and Investor Conference in New York City, at 12:30 p.m. EST on February 12, 2008. Presenting on behalf of the Company will be Richard B. Hollis, Chairman and Chief Executive Officer. A live webcast of the presentation will be available from the conference. Investors may access the webcast under “Event Calendar” on the Investors section of Hollis-Eden’s website at www.holliseden.com. The webcast will be archived at the Company’s website for 30 days following the presentation.
